Evaluate FHTX stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in FHTX? | Glauxie AI

Q: What are the risks of investing in FHTX?

Foghorn Therapeutics Inc. (FHTX) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Adrian H. Gottschalk. Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The... Employees: 106.

Q: How much debt does FHTX have?

Review FHTX total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is FHTX a good long-term investment?

Evaluate FHTX as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in FHTX?

🦉

Foghorn Therapeutics Inc. (FHTX)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOAdrian H. Gottschalk

Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug...

Key Executives

Name	Title
Adrian H. Gottschalk	President, Chief Executive Officer & Director
Alfonso Quintas Cardama	Chief Medical Officer
Anna Rivkin	Chief Business Officer
Carlos Costa	Chief People Officer
Gerald R. Crabtree	Founder & Member of Scientific Advisory Board
Jeffrey Sacher	Treasurer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

FHTX Profile Financials

Is FHTX stock safe? How much debt does FHTX have? Is FHTX a good long-term investment?